March 20, 2020 / 2:55 PM / 9 days ago

BRIEF-Sartorius Says European, U.S. Antitrust Authorities Clear Acquisition Of Select Danaher Life Science Businesses

March 20 (Reuters) - Sartorius Stedim Biotech SA:

* EUROPEAN AND U.S. ANTITRUST AUTHORITIES CLEAR ACQUISITION OF SELECT DANAHER LIFE SCIENCE BUSINESSES BY SARTORIUS STEDIM BIOTECH

* TRANSACTION IS NOW EXPECTED TO CLOSE IN Q2 OF 2020

* BUSINESSES TO BE ACQUIRED ARE PART OF DANAHER’S LIFE SCIENCES PLATFORM AND ALSO INCLUDE VARIOUS BIOPROCESSING TECHNOLOGIES THAT ARE A COMPLEMENTARY FIT TO PORTFOLIO OF BUSINESSES OF SSB

* TOTAL PURCHASE PRICE IS APPROXIMATELY 825 MILLION U.S. DOLLARS IN CASH OF WHICH ABOUT A THIRD WILL BE ALLOCATED TO BUSINESSES PURCHASED BY SARTORIUS STEDIM BIOTECH

* COMPLETION OF TRANSACTION IS STILL SUBJECT TO CLEARANCE BY CHINESE ANTITRUST ENFORCEMENT AUTHORITY OF SARTORIUS AS BUYER OF ASSETS

* IN 2019, SALES OF THE BUSINESSES TO BE ACQUIRED BY SSB WERE CLOSE TO 100 MILLION U.S. DOLLARS Source text for Eikon: Further company coverage:, (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below